文献速递关节外科

解剖型全肩关节置换术患者报告结局指标与健康相关生活质量评分

Patient-Reported Outcome Measures and Health-Related Quality-of-Life Scores of Patients Undergoing Anatomic Total Shoulder Arthroplasty.
PubMed 文献 · J Bone Joint Surg Am · 2020-01-01

研究纳入143例(143肩)晚期盂肱骨关节炎接受解剖型全肩关节置换术患者,其中92例有1年随访;术后1年所有患者报告结局指标(PROMs)和健康相关生活质量(HRQoL)评分均显著改善(p<0.001),HRQoL评分与PROMs变化显著相关(p<0.05),且HRQoL评分具有大效应量和大标准化反应均值。

要点

  • 术后1年PROMs和HRQoL评分均较术前显著改善(p<0.001)。
  • VAS QoL、EQ-5D和SF-6D的变化与PROMs变化显著相关(p<0.05),效度可接受。
  • PROMs与HRQoL评分不可互换,成本效果分析应同时纳入两者。

核心结论

  • PROMs与HRQoL评分不可互换,肩关节置换的成本效果和价值研究应同时纳入肩关节和上肢PROMs及HRQoL评分。
  • 本研究提供了晚期盂肱骨关节炎解剖型全肩关节置换术特有的HRQoL评分数据,可用于未来成本效果和价值分析研究。

研究设计与样本

  • 研究分析了143例(143肩)接受解剖型全肩关节置换术的盂肱骨关节炎患者,其中92例有1年随访。
  • 术前和术后功能结局采用DASH评分、ASES评分、SST和肩痛与功能VAS评估。
  • 健康效用采用EQ-5D、SF-6D和VAS生活质量(VAS QoL)评估。
  • HRQoL评分效度通过PROMs与HRQoL评分的相关性确定,反应性通过效应量和标准化反应均值衡量。

主要发现

  • 术后1年所有PROMs和HRQoL评分均显著改善(p<0.001)。
  • VAS QoL(极弱至中度)、EQ-5D(弱)和SF-6D(弱)的变化与PROMs变化显著相关(p<0.05),效度可接受。
  • VAS QoL效应量为1.843,EQ-5D为1.186,SF-6D为1.084,均属大效应量。
  • VAS QoL标准化反应均值为1.622,EQ-5D为1.230,SF-6D为1.083,均属大标准化反应均值。
  • 所有PROMs的效应量均大于HRQoL评分的效应量。

局限性

  • 证据等级为治疗性IV级。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Health-related quality-of-life (HRQoL) scores are required for cost-effectiveness and health-care value analysis. We evaluated HRQoL scores and patient-reported outcome measures (PROMs) in patients with advanced glenohumeral osteoarthritis treated with anatomic total shoulder arthroplasty to establish values of HRQoL scores that can be used for cost-effectiveness and value analysis and to assess relationships between HRQoL scores and shoulder and upper-extremity PROMs. METHODS: We analyzed 143 patients (143 shoulders) with glenohumeral osteoarthritis treated with anatomic total shoulder arthroplasty; 92 patients had 1-year follow-up. Preoperative and postoperative functional outcomes were assessed with the Disabilities of the Arm, Shoulder and Hand (DASH) score, the American Shoulder and Elbow Surgeons (ASES) score, the Simple Shoulder Test (SST), and a visual analog scale (VAS) for shoulder pain and function. Health utility was assessed with the EuroQol-5 Dimensions (EQ-5D), Short Form-6 Dimensions (SF-6D), and VAS Quality of Life (VAS QoL). HRQoL score validity was determined through correlations between the PROMs and HRQoL scores. The responsiveness of HRQoL scores was measured through the effect size and the standardized response mean. RESULTS: There were significant improvements in all PROMs and HRQoL scores (p < 0.001) at 1 year after the surgical procedure. The changes in VAS QoL (very weak to moderate), EQ-5D (weak), and SF-6D (weak) were significantly correlated (p < 0.05) with the changes in PROMs, demonstrating comparably acceptable validity. There were large effect sizes in the VAS QoL (1.843), EQ-5D (1.186), and SF-6D (1.084) and large standardized response mean values in the VAS QoL (1.622), EQ-5D (1.230), and SF-6D (1.083), demonstrating responsiveness. The effect sizes of all PROMs were larger than those of the HRQoL scores. CONCLUSIONS: PROMs and HRQoL scores are not interchangeable, and studies of the cost-effectiveness and value of shoulder arthroplasty should incorporate both shoulder and upper-extremity PROMs and HRQoL scores. The findings of this study provide data on HRQoL scores that are specific to the treatment of advanced glenohumeral osteoarthritis with anatomic total shoulder arthroplasty and can be used for future cost-effectiveness and value analysis studies. LEVEL OF EVIDENCE: Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Jain SS, DeFroda SF, Paxton ES, et al. Patient-Reported Outcome Measures and Health-Related Quality-of-Life Scores of Patients Undergoing Anatomic Total Shoulder Arthroplasty. J Bone Joint Surg Am. 2020. PMID: 32618926. doi:10.2106/JBJS.20.00402

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。